Journal of General Internal Medicine / Mar 01, 2004

Rich, E. C., Burke, W., Heaton, C. J., Haga, S., Pinsky, L., Short, M. P., & Acheson, L. (2004). Reconsidering the family history in primary care. Journal of General Internal Medicine, 19(3), 273–280. https://doi.org/10.1111/j.1525-1497.2004.30401.x

Clinical Genetics / Jul 03, 2012

Haga, S., Burke, W., Ginsburg, G., Mills, R., & Agans, R. (2012). Primary care physicians’ knowledge of and experience with pharmacogenetic testing. Clinical Genetics, 82(4), 388–394. Portico. https://doi.org/10.1111/j.1399-0004.2012.01908.x

Genetic Testing and Molecular Biomarkers / Apr 01, 2013

Haga, S. B., Barry, W. T., Mills, R., Ginsburg, G. S., Svetkey, L., Sullivan, J., & Willard, H. F. (2013). Public Knowledge of and Attitudes Toward Genetics and Genetic Testing. Genetic Testing and Molecular Biomarkers, 17(4), 327–335. https://doi.org/10.1089/gtmb.2012.0350

Nature Genetics / Aug 01, 2003

Haga, S. B., Khoury, M. J., & Burke, W. (2003). Genomic profiling to promote a healthy lifestyle: not ready for prime time. Nature Genetics, 34(4), 347–350. https://doi.org/10.1038/ng0803-347

Genetic Dissection of Complex Traits / Jan 01, 2008

Haga, S. B., & Beskow, L. M. (2008). Ethical, Legal, and Social Implications of Biobanks for Genetics Research. In Advances in Genetics (pp. 505–544). Elsevier. https://doi.org/10.1016/s0065-2660(07)00418-x

The Pharmacogenomics Journal / Feb 15, 2011

Haga, S. B., O’Daniel, J. M., Tindall, G. M., Lipkus, I. R., & Agans, R. (2011). Survey of US public attitudes toward pharmacogenetic testing. The Pharmacogenomics Journal, 12(3), 197–204. https://doi.org/10.1038/tpj.2011.1

Jan 01, 1999

Handbook of Human Tissue Sources: A National Resource of Human Tissue Samples. (1999). RAND Corporation. https://doi.org/10.7249/mr954

Genetics in Medicine / Feb 01, 2010

Haga, S. B. (2010). Impact of limited population diversity of genome-wide association studies. Genetics in Medicine, 12(2), 81–84. https://doi.org/10.1097/gim.0b013e3181ca2bbf

Journal of Personalized Medicine / Oct 30, 2012

Hresko, A., & Haga, S. (2012). Insurance Coverage Policies for Personalized Medicine. Journal of Personalized Medicine, 2(4), 201–216. https://doi.org/10.3390/jpm2040201

Journal of Personalized Medicine / May 24, 2019

Haga, S. B., Kim, E., Myers, R. A., & Ginsburg, G. S. (2019). Primary Care Physicians’ Knowledge, Attitudes, and Experience with Personal Genetic Testing. Journal of Personalized Medicine, 9(2), 29. https://doi.org/10.3390/jpm9020029

Leukemia / Nov 01, 2000

Haga, S., Fu, S., Karp, J., Ross, D., Williams, D., Hankins, W., Behm, F., Ruscetti, F., Chang, M., Smith, B., Becton, D., Raimondi, S., & Berg, P. (2000). BP1, a new homeobox gene, is frequently expressed in acute leukemias. Leukemia, 14(11), 1867–1875. https://doi.org/10.1038/sj.leu.2401912

Pharmacogenomics / Jun 01, 2013

Mills, R., & Haga, S. B. (2013). Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists. Pharmacogenomics, 14(8), 957–968. https://doi.org/10.2217/pgs.13.76

Public Health Genomics / Jan 01, 2011

O’Daniel, J., & Haga, S. B. (2011). Public Perspectives on Returning Genetics and Genomics Research Results. Public Health Genomics, 14(6), 346–355. Portico. https://doi.org/10.1159/000324933

Expert Review of Molecular Diagnostics / Mar 01, 2006

Ginsburg, G. S., & Haga, S. B. (2006). Translating genomic biomarkers into clinically useful diagnostics. Expert Review of Molecular Diagnostics, 6(2), 179–191. https://doi.org/10.1586/14737159.6.2.179

Journal of General Internal Medicine / Feb 11, 2011

Haga, S. B., Carrig, M. M., O’Daniel, J. M., Orlando, L. A., Killeya-Jones, L. A., Ginsburg, G. S., & Cho, A. (2011). Genomic Risk Profiling: Attitudes and Use in Personal and Clinical Care of Primary Care Physicians Who Offer Risk Profiling. Journal of General Internal Medicine, 26(8), 834–840. https://doi.org/10.1007/s11606-011-1651-7

Genome Medicine / Jul 31, 2014

Haga, S. B., Mills, R., Pollak, K. I., Rehder, C., Buchanan, A. H., Lipkus, I. M., Crow, J. H., & Datto, M. (2014). Developing patient-friendly genetic and genomic test reports: formats to promote patient engagement and understanding. Genome Medicine, 6(7). https://doi.org/10.1186/s13073-014-0058-6

The Pharmacogenomics Journal / Sep 03, 2013

Haga, S. B., & LaPointe, N. M. A. (2013). The potential impact of pharmacogenetic testing on medication adherence. The Pharmacogenomics Journal, 13(6), 481–483. https://doi.org/10.1038/tpj.2013.33

Molecular and Cellular Biology / Apr 01, 2002

Chase, M. B., Fu, S., Haga, S. B., Davenport, G., Stevenson, H., Do, K., Morgan, D., Mah, A. L., & Berg, P. E. (2002). BP1, a Homeodomain-Containing Isoform of DLX4, Represses the β-Globin Gene. Molecular and Cellular Biology, 22(8), 2505–2514. https://doi.org/10.1128/mcb.22.8.2505-2514.2002

Genetics in Medicine / Jun 01, 2008

Haga, S. B., & Burke, W. (2008). Pharmacogenetic testing: not as simple as it seems. Genetics in Medicine, 10(6), 391–395. https://doi.org/10.1097/gim.0b013e31817701d4

Genetics in Medicine / Aug 01, 2013

Clayton, E. W., Haga, S., Kuszler, P., Bane, E., Shutske, K., & Burke, W. (2013). Managing incidental genomic findings: legal obligations of clinicians. Genetics in Medicine, 15(8), 624–629. https://doi.org/10.1038/gim.2013.7

Genetic Testing and Molecular Biomarkers / Mar 01, 2012

Haga, S. B., Tindall, G., & O’Daniel, J. M. (2012). Public Perspectives About Pharmacogenetic Testing and Managing Ancillary Findings. Genetic Testing and Molecular Biomarkers, 16(3), 193–197. https://doi.org/10.1089/gtmb.2011.0118

Public Health Genomics / Jan 01, 2011

Haga, S. B., & O’Daniel, J. (2011). Public Perspectives Regarding Data-Sharing Practices in Genomics Research. Public Health Genomics, 14(6), 319–324. Portico. https://doi.org/10.1159/000324705

Science / Jul 25, 2003

Haga, S. B., & Venter, J. C. (2003). FDA Races in Wrong Direction. Science, 301(5632), 466–466. https://doi.org/10.1126/science.1087004

Genetic Testing and Molecular Biomarkers / Jan 01, 2012

Haga, S. B., Tindall, G., & O’Daniel, J. M. (2012). Professional Perspectives About Pharmacogenetic Testing and Managing Ancillary Findings. Genetic Testing and Molecular Biomarkers, 16(1), 21–24. https://doi.org/10.1089/gtmb.2011.0045

JAMA / Jun 16, 2004

Haga, S. B. (2004). Using Pharmacogenetics to Improve Drug Safety and Efficacy. JAMA, 291(23), 2869. https://doi.org/10.1001/jama.291.23.2869

Clinical Genetics / Feb 19, 2012

Haga, S., O’Daniel, J., Tindall, G., Mills, R., Lipkus, I., & Agans, R. (2012). Survey of genetic counselors and clinical geneticists’ use and attitudes toward pharmacogenetic testing. Clinical Genetics, 82(2), 115–120. Portico. https://doi.org/10.1111/j.1399-0004.2012.01848.x

Pharmacogenetics and Genomics / Dec 01, 2006

Haga, S. B., Thummel, K. E., & Burke, W. (2006). Adding pharmacogenetics information to drug labels: lessons learned. Pharmacogenetics and Genomics, 16(12), 847–854. https://doi.org/10.1097/01.fpc.0000236322.88433.ac

Gene / Oct 01, 2001

Fu, S., Stevenson, H., Strovel, J. W., Haga, S. B., Stamberg, J., Do, K., & Berg, P. E. (2001). Distinct functions of two isoforms of a homeobox gene, BP1 and DLX7, in the regulation of the β-globin gene. Gene, 278(1–2), 131–139. https://doi.org/10.1016/s0378-1119(01)00716-8

Health Affairs / May 01, 2018

Haga, S. B., & Kantor, A. (2018). Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing. Health Affairs, 37(5), 717–723. https://doi.org/10.1377/hlthaff.2017.1564

Pharmacogenetics and Genomics / Mar 01, 2014

Haga, S. B., & Moaddeb, J. (2014). Comparison of delivery strategies for pharmacogenetic testing services. Pharmacogenetics and Genomics, 24(3), 139–145. https://doi.org/10.1097/fpc.0000000000000028

Genetics in Medicine / Aug 01, 2011

Haga, S. B., O’Daniel, J. M., Tindall, G. M., Lipkus, I. R., & Agans, R. (2011). Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions. Genetics in Medicine, 13(8), 723–728. https://doi.org/10.1097/gim.0b013e31821afcc0

BMC Health Services Research / Jan 18, 2012

Cho, A. H., Killeya-Jones, L. A., O’Daniel, J. M., Kawamoto, K., Gallagher, P., Haga, S., Lucas, J. E., Trujillo, G. M., Joy, S. V., & Ginsburg, G. S. (2012). Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design. BMC Health Services Research, 12(1). https://doi.org/10.1186/1472-6963-12-16

Journal of the American Pharmacists Association / Nov 01, 2015

Moaddeb, J., Mills, R., & Haga, S. B. (2015). Community pharmacists’ experience with pharmacogenetic testing. Journal of the American Pharmacists Association, 55(6), 587–594. https://doi.org/10.1331/japha.2015.15017

Pharmacogenomics / Oct 01, 2016

Haga, S. B., Mills, R., Moaddeb, J., Allen Lapointe, N., Cho, A., & Ginsburg, G. S. (2016). Patient experiences with pharmacogenetic testing in a primary care setting. Pharmacogenomics, 17(15), 1629–1636. https://doi.org/10.2217/pgs-2016-0077

Therapeutic Advances in Drug Safety / May 02, 2013

Moaddeb, J., & Haga, S. B. (2013). Pharmacogenetic testing: current evidence of clinical utility. Therapeutic Advances in Drug Safety, 4(4), 155–169. https://doi.org/10.1177/2042098613485595

Nature Reviews Genetics / Feb 07, 2006

Haga, S. B. (2006). Teaching resources for genetics. Nature Reviews Genetics, 7(3), 223–229. https://doi.org/10.1038/nrg1803

Pharmacogenomics and Personalized Medicine / Sep 01, 2013

Mills, R., Voora, D., Peyser, B., & Haga, S. (2013). Delivering pharmacogenetic testing in a primary care setting. Pharmacogenomics and Personalized Medicine, 105. https://doi.org/10.2147/pgpm.s50598

Pharmacogenomics / Nov 01, 2015

Haga, S. B., Moaddeb, J., Mills, R., Patel, M., Kraus, W., & Allen LaPointe, N. M. (2015). Incorporation of pharmacogenetic testing into medication therapy management. Pharmacogenomics, 16(17), 1931–1941. https://doi.org/10.2217/pgs.15.124

Circulation: Genomic and Precision Medicine / Sep 01, 2018

Peyser, B., Perry, E. P., Singh, K., Gill, R. D., Mehan, M. R., Haga, S. B., Musty, M. D., Milazzo, N. A., Savard, D., Li, Y.-J., Trujilio, G., & Voora, D. (2018). Effects of Delivering SLCO1B1 Pharmacogenetic Information in Randomized Trial and Observational Settings. Circulation: Genomic and Precision Medicine, 11(9). https://doi.org/10.1161/circgen.118.002228

Genetic Testing and Molecular Biomarkers / Dec 01, 2010

Heaney, C., Tindall, G., Lucas, J., & Haga, S. B. (2010). Researcher Practices on Returning Genetic Research Results. Genetic Testing and Molecular Biomarkers, 14(6), 821–827. https://doi.org/10.1089/gtmb.2010.0066

Race Ethnicity and Education / Nov 01, 2012

EDITORIAL BOARD. (2012). Race Ethnicity and Education, 15(5), ebi-ebi. https://doi.org/10.1080/13613324.2012.736166

Journal of Personalized Medicine / Mar 27, 2014

Li, J., Joy, S., Haga, S., Orlando, L., Kraus, W., Ginsburg, G., & Voora, D. (2014). Genetically Guided Statin Therapy on Statin Perceptions, Adherence, and Cholesterol Lowering: A Pilot Implementation Study in Primary Care Patients. Journal of Personalized Medicine, 4(2), 147–162. https://doi.org/10.3390/jpm4020147

Nature Reviews Genetics / Dec 01, 2006

Haga, S. B., & Willard, H. F. (2006). Defining the spectrum of genome policy. Nature Reviews Genetics, 7(12), 966–972. https://doi.org/10.1038/nrg2003

Journal of Genetic Counseling / Sep 12, 2013

Mills, R., & Haga, S. B. (2013). Genomic Counseling: Next Generation Counseling. Journal of Genetic Counseling, 23(4), 689–692. Portico. https://doi.org/10.1007/s10897-013-9641-z

Public Health Genomics / May 04, 2009

O’Daniel, J., Lucas, J., Deverka, P., Ermentrout, D., Silvey, G., Lobach, D. F., & Haga, S. B. (2009). Factors Influencing Uptake of Pharmacogenetic Testing in a Diverse Patient Population. Public Health Genomics, 13(1), 48–54. Portico. https://doi.org/10.1159/000217795

American Journal of Hematology / Jan 01, 1999

Chase, M. B., Haga, S. B., Hankins, W. D., Williams, D. M., Bi, Z., Strovel, J. W., Obriecht, C., & Berg, P. E. (1999). Binding of HMG-I(Y) elicits structural changes in a silencer of the human ?-globin gene. American Journal of Hematology, 60(1), 27–35. https://doi.org/10.1002/(sici)1096-8652(199901)60:1<27::aid-ajh6>3.0.co;2-0

Journal of Personalized Medicine / Jul 01, 2019

Villegas, C., & Haga, S. B. (2019). Access to Genetic Counselors in the Southern United States. Journal of Personalized Medicine, 9(3), 33. https://doi.org/10.3390/jpm9030033

Genetics in Medicine / Jul 01, 2013

Haga, S. B., Burke, W., & Agans, R. (2013). Primary-care physicians’ access to genetic specialists: an impediment to the routine use of genomic medicine? Genetics in Medicine, 15(7), 513–514. https://doi.org/10.1038/gim.2012.168

Expert Review of Molecular Diagnostics / Jul 22, 2016

Haga, S. B. (2016). Challenges of development and implementation of point of care pharmacogenetic testing. Expert Review of Molecular Diagnostics, 16(9), 949–960. https://doi.org/10.1080/14737159.2016.1211934

Public Health Genomics / Jan 01, 2014

Haga, S. B., Barry, W. T., Mills, R., Svetkey, L., Suchindran, S., Willard, H. F., & Ginsburg, G. S. (2014). Impact of Delivery Models on Understanding Genomic Risk for Type 2 Diabetes. Public Health Genomics, 17(2), 95–104. Portico. https://doi.org/10.1159/000358413

Journal of Genetic Counseling / Mar 30, 2010

O’Daniel, J. M., Haga, S. B., & Willard, H. F. (2010). Considerations for the Impact of Personal Genome Information: A Study of Genomic Profiling among Genetics and Genomics Professionals. Journal of Genetic Counseling, 19(4), 387–401. Portico. https://doi.org/10.1007/s10897-010-9297-x

Pharmacogenomics / Jun 01, 2019

Haga, S. B., & Moaddeb, J. (2019). Pharmacogenomics courses in pharmacy school curricula. Pharmacogenomics, 20(9), 625–630. https://doi.org/10.2217/pgs-2019-0024

Pharmacogenomics / Sep 01, 2014

Haga, S. B., Allen LaPointe, N. M., Cho, A., Reed, S. D., Mills, R., Moaddeb, J., & Ginsburg, G. S. (2014). Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting. Pharmacogenomics, 15(13), 1677–1686. https://doi.org/10.2217/pgs.14.109

Journal of Managed Care & Specialty Pharmacy / Apr 01, 2015

Haga, S. B., LaPointe, N. M. A., & Moaddeb, J. (2015). Challenges to Integrating Pharmacogenetic Testing into Medication Therapy Management. Journal of Managed Care &amp; Specialty Pharmacy, 21(4), 346–352. https://doi.org/10.18553/jmcp.2015.21.4.346

Pharmacogenomics / Oct 01, 2019

Weitzel, K. W., Duong, B. Q., Arwood, M. J., Owusu-Obeng, A., Abul-Husn, N. S., Bernhardt, B. A., Decker, B., Denny, J. C., Dietrich, E., Gums, J., Madden, E. B., Pollin, T. I., Wu, R. R., Haga, S. B., & Horowitz, C. R. (2019). A stepwise approach to implementing pharmacogenetic testing in the primary care setting. Pharmacogenomics, 20(15), 1103–1112. https://doi.org/10.2217/pgs-2019-0053

Patient Education and Counseling / Oct 01, 2014

Haga, S. B., Mills, R., & Bosworth, H. (2014). Striking a balance in communicating pharmacogenetic test results: Promoting comprehension and minimizing adverse psychological and behavioral response. Patient Education and Counseling, 97(1), 10–15. https://doi.org/10.1016/j.pec.2014.06.007

Pharmacogenomics / Mar 01, 2017

Haga, S. B., Mills, R., Moaddeb, J., Allen LaPointe, N., Cho, A., & Ginsburg, G. S. (2017). Primary care providers’ use of pharmacist support for delivery of pharmacogenetic testing. Pharmacogenomics, 18(4), 359–367. https://doi.org/10.2217/pgs-2016-0177

Public Health Genomics / Jan 01, 2009

Haga, S. B., Warner, L. R., & O’Daniel, J. (2009). The Potential of a Placebo/Nocebo Effect in Pharmacogenetics. Public Health Genomics, 12(3), 158–162. Portico. https://doi.org/10.1159/000189628

Genetics in Medicine / Oct 01, 2011

Haga, S. B., Kawamoto, K., Agans, R., & Ginsburg, G. S. (2011). Consideration of patient preferences and challenges in storage and access of pharmacogenetic test results. Genetics in Medicine, 13(10), 887–890. https://doi.org/10.1097/gim.0b013e31822077a5

Pharmacopsychiatry / Sep 11, 2019

Brown, L., Eum, S., Haga, S. B., Strawn, J. R., & Zierhut, H. (2019). Clinical Utilization of Pharmacogenetics in Psychiatry – Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry. Pharmacopsychiatry, 53(04), 162–173. https://doi.org/10.1055/a-0975-9595

Genetics in Medicine / Feb 01, 2012

O’Daniel, J. M., Rosanbalm, K. D., Boles, L., Tindall, G. M., Livingston, T. M., & Haga, S. B. (2012). Enhancing geneticists’ perspectives of the public through community engagement. Genetics in Medicine, 14(2), 243–249. https://doi.org/10.1038/gim.2011.29

Journal of Diabetes Science and Technology / Jul 01, 2009

Haga, S. B. (2009). Ethical Issues of Predictive Genetic Testing for Diabetes. Journal of Diabetes Science and Technology, 3(4), 781–788. https://doi.org/10.1177/193229680900300427

Journal of Personalized Medicine / May 25, 2017

Mills, R., Ensinger, M., Callanan, N., & Haga, S. (2017). Development and Initial Assessment of a Patient Education Video about Pharmacogenetics. Journal of Personalized Medicine, 7(2), 4. https://doi.org/10.3390/jpm7020004

Pharmacogenomics / Sep 01, 2016

Haga, S. B., & Mills, R. (2016). A review of consent practices and perspectives for pharmacogenetic testing. Pharmacogenomics, 17(14), 1595–1605. https://doi.org/10.2217/pgs-2016-0039

Journal of Genetic Counseling / Jun 14, 2014

Mills, R., Powell, J., Barry, W., & Haga, S. B. (2014). Information‐Seeking and Sharing Behavior Following Genomic Testing for Diabetes Risk. Journal of Genetic Counseling, 24(1), 58–66. Portico. https://doi.org/10.1007/s10897-014-9736-1

Pharmacogenomics / Sep 01, 2016

Haga, S. B., Mills, R., & Moaddeb, J. (2016). Evaluation of a pharmacogenetic educational toolkit for community pharmacists. Pharmacogenomics, 17(14), 1491–1502. https://doi.org/10.2217/pgs-2016-0002

Pharmacogenomics and Personalized Medicine / Oct 01, 2014

Mills, R., Haga, S., & Moaddeb, J. (2014). Pharmacogenetic information for patients on drug labels. Pharmacogenomics and Personalized Medicine, 297. https://doi.org/10.2147/pgpm.s67876

Advances in Genetics / Jan 01, 2013

Haga, S. B., & Zhao, J. Q. (2013). Stakeholder Views on Returning Research Results. In Advances in Genetics (pp. 41–81). Elsevier. https://doi.org/10.1016/b978-0-12-407703-4.00002-5

Journal of Genetic Counseling / Feb 23, 2013

Haga, S. B., Rosanbalm, K. D., Boles, L., Tindall, G. M., Livingston, T. M., & O’Daniel, J. M. (2013). Promoting Public Awareness and Engagement in Genome Sciences. Journal of Genetic Counseling, 22(4), 508–516. Portico. https://doi.org/10.1007/s10897-013-9577-3

Pharmacogenomics / Nov 01, 2014

Haga, S. B., Allen LaPointe, N. M., Moaddeb, J., Mills, R., Patel, M., & Kraus, W. E. (2014). Pilot study: incorporation of pharmacogenetic testing in medication therapy management services. Pharmacogenomics, 15(14), 1729–1737. https://doi.org/10.2217/pgs.14.118

PLOS ONE / Oct 25, 2019

Madhavan, S., Bullis, E., Myers, R., Zhou, C. J., Cai, E. M., Sharma, A., Bhatia, S., Orlando, L. A., & Haga, S. B. (2019). Awareness of family health history in a predominantly young adult population. PLOS ONE, 14(10), e0224283. https://doi.org/10.1371/journal.pone.0224283

Journal of Genetic Counseling / Aug 19, 2015

Arora, S., Haverfield, E., Richard, G., Haga, S. B., & Mills, R. (2015). Clinical and Counseling Experiences of Early Adopters of Whole Exome Sequencing. Journal of Genetic Counseling, 25(2), 337–343. Portico. https://doi.org/10.1007/s10897-015-9876-y

Pharmacogenomics / Dec 01, 2010

Surh, L. C., Pacanowski, M. A., Haga, S. B., Hobbs, S., Lesko, L. J., Gottlieb, S., Papaluca-Amati, M., Patterson, S. D., Hughes, A. R., Kim, M.-J., Close, S. L., Mosteller, M., Zineh, I., Dechairo, B., & Cohen, N. A. (2010). Learning from product labels and label changes: how to build pharmacogenomics into drug-development programs. Pharmacogenomics, 11(12), 1637–1647. https://doi.org/10.2217/pgs.10.138

Journal of the American College of Cardiology / Jul 01, 2006

Haga, S. B., & Ginsburg, G. S. (2006). Prescribing BiDil. Journal of the American College of Cardiology, 48(1), 12–14. https://doi.org/10.1016/j.jacc.2006.04.017

Pharmacogenomics / Mar 01, 2017

Haga, S. B., Moaddeb, J., Mills, R., & Voora, D. (2017). Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting. Pharmacogenomics, 18(4), 327–335. https://doi.org/10.2217/pgs-2016-0175

Pharmacogenomics and Personalized Medicine / Oct 01, 2019

Haga, S. B. (2019). &lt;p&gt;Pharmacogenomic Testing In Pediatrics: Navigating The Ethical, Social, And Legal Challenges&lt;/p&gt; Pharmacogenomics and Personalized Medicine, Volume 12, 273–285. https://doi.org/10.2147/pgpm.s179172

Pharmacogenomics / Jul 01, 2017

Haga, S. B. (2017). Educating patients and providers through comprehensive pharmacogenetic test reports. Pharmacogenomics, 18(11), 1047–1050. https://doi.org/10.2217/pgs-2017-0088

Genetic Testing and Molecular Biomarkers / Oct 01, 2010

Haga, S. B. (2010). Analysis of Educational Materials and Destruction/Opt-Out Initiatives for Storage and Use of Residual Newborn Screening Samples. Genetic Testing and Molecular Biomarkers, 14(5), 587–592. https://doi.org/10.1089/gtmb.2010.0010

Pharmacogenomics and Personalized Medicine / Jul 01, 2021

Haga, S. B., Mills, R., Moaddeb, J., Liu, Y., & Voora, D. (2021). Independent Community Pharmacists’ Experience in Offering Pharmacogenetic Testing. Pharmacogenomics and Personalized Medicine, Volume 14, 877–886. https://doi.org/10.2147/pgpm.s314972

Pharmacogenomics / Mar 01, 2015

Haga, S. B., & Mills, R. (2015). Nurses’ communication of pharmacogenetic test results as part of discharge care. Pharmacogenomics, 16(3), 251–256. https://doi.org/10.2217/pgs.14.173

Molecular Diagnosis & Therapy / Jun 07, 2019

Haga, S. B. (2019). First Responder to Genomic Information: A Guide for Primary Care Providers. Molecular Diagnosis &amp; Therapy, 23(4), 459–466. https://doi.org/10.1007/s40291-019-00407-z

Pharmacogenomics and Personalized Medicine / Sep 01, 2018

Mills, R., & Haga, S. B. (2018). Qualitative user evaluation of a revised pharmacogenetic educational toolkit. Pharmacogenomics and Personalized Medicine, Volume 11, 139–146. https://doi.org/10.2147/pgpm.s169648

Expert Review of Precision Medicine and Drug Development / Nov 02, 2017

Haga, S. B. (2017). Integrating pharmacogenetic testing into primary care. Expert Review of Precision Medicine and Drug Development, 2(6), 327–336. https://doi.org/10.1080/23808993.2017.1398046

Journal of Personalized Medicine / Jan 14, 2021

Kantor, A., & Haga, S. B. (2021). The Potential Benefit of Expedited Development and Approval Programs in Precision Medicine. Journal of Personalized Medicine, 11(1), 45. https://doi.org/10.3390/jpm11010045

Expert Opinion on Drug Safety / May 22, 2020

Haga, S. B. (2020). Toward digital-based interventions for medication adherence and safety. Expert Opinion on Drug Safety, 19(6), 735–746. https://doi.org/10.1080/14740338.2020.1764935

Clinical Pediatrics / May 15, 2009

Haga, S. B., & Terry, S. F. (2009). Ensuring the Safe Use of Genomic Medicine in Children. Clinical Pediatrics, 48(7), 703–708. https://doi.org/10.1177/0009922809335736

Public Health Genomics / Sep 07, 2021

Sharma, Y., Cox, L., Kruger, L., Channamsetty, V., & Haga, S. B. (2021). Evaluating Primary Care Providers’ Readiness for Delivering Genetic and Genomic Services to Underserved Populations. Public Health Genomics, 25(1–2), 12–21. Portico. https://doi.org/10.1159/000518415

Applied Clinical Informatics / Mar 01, 2019

Wu, R., Myers, R., Buchanan, A., Dimmock, D., Fulda, K., Haller, I., Haga, S., Harry, M., McCarty, C., Neuner, J., Rakhra-Burris, T., Sperber, N., Voils, C., Ginsburg, G., & Orlando, L. (2019). Effect of Sociodemographic Factors on Uptake of a Patient-Facing Information Technology Family Health History Risk Assessment Platform. Applied Clinical Informatics, 10(02), 180–188. https://doi.org/10.1055/s-0039-1679926

Pharmacogenomics / Nov 01, 2017

Huddleston, K. L., Klein, E., Fuller, A., Jo, G., Lawrence, G., & Haga, S. B. (2017). Introducing personalized health for the family: the experience of a single hospital system. Pharmacogenomics, 18(17), 1589–1594. https://doi.org/10.2217/pgs-2017-0112

Journal of Health Communication / Apr 06, 2015

Gallagher, P., King, H. A., Haga, S. B., Orlando, L. A., Joy, S. V., Trujillo, G. M., Scott, W. M., Bembe, M., Creighton, D. L., Cho, A. H., Ginsburg, G. S., & Vorderstrasse, A. (2015). Patient Beliefs and Behaviors About Genomic Risk for Type 2 Diabetes: Implications for Prevention. Journal of Health Communication, 20(6), 728–735. https://doi.org/10.1080/10810730.2015.1018563

Adolescent Health, Medicine and Therapeutics / Feb 01, 2022

Bond, S. J., Parikh, N., Majmudar, S., Pin, S., Wang, C., Willis, L., & Haga, S. B. (2022). A Systematic Review of the Scope of Study of mHealth Interventions for Wellness and Related Challenges in Pediatric and Young Adult Populations. Adolescent Health, Medicine and Therapeutics, Volume 13, 23–38. https://doi.org/10.2147/ahmt.s342811

Frontiers in Genetics / Oct 01, 2021

Haga, S. B. (2021). Revisiting Secondary Information Related to Pharmacogenetic Testing. Frontiers in Genetics, 12. https://doi.org/10.3389/fgene.2021.741395

Personalized Medicine / May 01, 2020

Haga, S. B., & Orlando, L. A. (2020). The enduring importance of family health history in the era of genomic medicine and risk assessment. Personalized Medicine, 17(3), 229–239. https://doi.org/10.2217/pme-2019-0091

Personalized Medicine / Mar 01, 2017

Haga, S. B. (2017). Update: looking beyond the 100,000 Genome Project. Personalized Medicine, 14(2), 85–87. https://doi.org/10.2217/pme-2016-0101

Clinical Chemistry / Jan 01, 2015

Deverka, P. A., & Haga, S. B. (2015). Comparative Effectiveness Research and Demonstrating Clinical Utility for Molecular Diagnostic Tests. Clinical Chemistry, 61(1), 142–144. https://doi.org/10.1373/clinchem.2014.223412

Pharmacogenomics / Jan 01, 2014

Haga, S. B. (2014). Delivering pharmacogenetic testing to the masses: an achievable goal? Pharmacogenomics, 15(1), 1–4. https://doi.org/10.2217/pgs.13.211

AMA Journal of Ethics / Aug 01, 2012

Genetic Testing: Clinical and Personal Utility. (2012). AMA Journal of Ethics, 14(8), 604–609. https://doi.org/10.1001/virtualmentor.2012.14.8.ecas1-1208

Clinical Pharmacology & Therapeutics / Jul 01, 2011

Haga, S. B., & Burke, W. (2011). Practical Ethics: Establishing a Pathway to Benefit for Complex Pharmacogenomic Tests. Clinical Pharmacology &amp; Therapeutics, 90(1), 25–27. https://doi.org/10.1038/clpt.2011.71

New England Journal of Medicine / May 15, 2008

Letting the Genome Out of the Bottle. (2008). New England Journal of Medicine, 358(20), 2184–2185. https://doi.org/10.1056/nejmc086053

Pharmacy / Sep 10, 2023

Haga, S. B. (2023). The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S. Pharmacy, 11(5), 144. https://doi.org/10.3390/pharmacy11050144

Journal of Personalized Medicine / Feb 25, 2023

Haga, S. B., & Orlando, L. A. (2023). Expanding Family Health History to Include Family Medication History. Journal of Personalized Medicine, 13(3), 410. https://doi.org/10.3390/jpm13030410